Board Meeting On 10 November 2017
The meeting of the Board of Directors of the Company is scheduled to be held on Friday, the 10th November 2017 to consider the Unaudited Financial Results for the quarter and half year ended 30th September 2017. Regulation 40(9) Of SEBI (LODR) Regulations, 2015
Certificate from Practicing Company Secretary under Regulation 40(9) of SEBI (LODR) Regulations, 2015 for the half year ended 30th September, 2017 Shareholding for the Period Ended September 30, 2017
Bafna Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2017. For more details, kindly Click here Statement Of Investor Complaints For Quarter Ended September 30, 2017
Statement of investor complaints for quarter ended September 30, 2017 Compliance Certificate As Per Regulation 7 Of SEBI (LODR) Regulations 2015 For Half Year Ended September 30, 2017
Compliance Certificate as per Regulation 7 of SEBI (LODR) Regulations 2015 for half year ended September 30, 2017 Appointment of Director
Appointment of Mr. Nirav Maniar as an Additional Director of the Company Outcome of AGM
Proceedings of Annual General Meeting held on September 30, 2017 - Regulation 30 of SEBI (LODR) Regulations 2015 